M MtoZ Biolabs
Home > Support > Resources > Unlabeled Quantitative Proteomics

Unlabeled Quantitative Proteomics

By Barbara Jackson · Published: November 16, 2026

Unlabeled quantitative proteomics names relative protein measurement on digests that enter mass spectrometry without isobaric or metabolic discovery tags on separate liquid chromatography-tandem mass spectrometry (LC-MS/MS) injections. In quantitative proteomics portfolios, it sits beside labeled multiplex routes and targeted remeasurement assays. The usual discovery readout is label-free quantification (LFQ) from MS1 precursor areas or from unlabeled data-independent acquisition (DIA) fragment traces after false discovery rate (FDR) control (Bantscheff et al. 2012; Cox et al. 2014). The guide below integrates unlabeled quantitative proteomics as a project theme with workflow, parameters, limits, and route choice. It is not a reagent catalog, not an instrument model list, and not a turnkey promise that one platform covers every matrix without documented scope.

Unlabeled quantitative tables support relative change across predefined groups in one study. They do not report molar amount on named peptides, clinical cutoffs, or interaction proof without separate targeted or functional design (Gerber et al. 2003).

In MtoZ Biolabs offerings, unlabeled quantitative proteomics is scoped when contrast design, matched pretreatment, and declared LFQ or unlabeled DIA processing fit the cohort block described in the project record.

LFQ terminology appears in LFQ. Chemistry contrast appears in What Is Label-Free Analysis?.

What Unlabeled Quantitative Proteomics Covers in a Project Record

Four scopes belong in the brief and stay separated.

Chemistry scope is unlabeled on discovery injections: no TMT, iTRAQ, or SILAC tags on the main contrast path unless a separate labeled block is declared.

Acquisition scope covers DDA, unlabeled DIA, or SWATH-style window plans with templates locked across the cohort block.

Metric scope is usually intensity-based LFQ. Spectral counting from peptide identification counts can support coarse screens but is a weak primary metric for group fold changes when MS1 areas exist on the same files.

Statistics scope covers normalization, missing-value policy, protein rollup, and testing on frozen contrasts only.

Unlabeled quantitative proteomics is a relative discovery theme. It does not replace enrollment design, replicate planning, or a signed methods appendix.

Broader quantitative framing appears in Exploring Quantitative Analysis in Proteomics. Route axes appear in Protein Quantification Method.

Unlabeled Metrics and Acquisition Routes Within Quantitative Proteomics

Quantitative proteomics can share hardware while differing in chemistry and readout.

MS1 peak-area LFQ integrates precursor chromatograms after peptide identification in DDA. MaxLFQ-style rollup uses peptide ratio relationships after delayed normalization (Cox et al. 2014).

Spectral counting compares assigned MS/MS counts per protein. It correlates with abundance in simple mixtures but is easily biased in complex lysates and complex enrichment pulls.

Unlabeled DIA quantifies extracted fragment traces under unified FDR (Gillet et al. 2012). Pilots often compare DDA missingness against DIA completeness before cohort scale.

Targeted parallel reaction monitoring (PRM) or stable isotope-labeled internal standard (SIS) assays are quantitative proteomics follow-ups, not synonyms for open unlabeled discovery.

Labeled TMT or SILAC blocks belong in the same quantitative proteomics map when multiplex or metabolic encoding fits enrollment.

Method survey appears in Mass Spectrometry-Based Quantitative Proteomics: Labeled and Label-Free Quantification Strategies. DIA depth appears in Label-Free DIA Quantitative Proteomics.

End-to-End Workflow for Unlabeled Quantitative Proteomics

A practical unlabeled quantitative spine usually runs as follows.

  1. Confirm matrix, contrast, relative claim, and whether DDA LFQ or unlabeled DIA fits the question.
  2. Prepare matched digests without discovery tags to injection-ready load.
  3. Run a pilot when matrix or enrichment type is new.
  4. Acquire separate LC-MS/MS injections with interleaved order when cohort size allows.
  5. Lock gradient, load, and acquisition template for the cohort block.
  6. Search with declared database, enzyme, modifications, and FDR.
  7. Extract unlabeled quantitative features; apply declared protein rollup.
  8. Normalize within study groups; document missing-value policy; run QC before statistics.
  9. Test predefined contrast only; archive methods and software versions with deliverables.

Steps 1 through 5 are experimental layers shared with Label-Free LC-MS/MS. Steps 6 through 9 complete the quantitative record.

Unlabeled quantitative proteomics workflow from matched unlabeled prep through LC-MS/MS acquisition, LFQ extraction, normalization, and contrast testing

Figure 1. Unlabeled quantitative proteomics requires one locked chain from prep through statistics; metric choice must stay consistent across the block.

Experiment handoff appears in A Guide to Label-Free Quantitative Proteomics: From Experiment to Data Analysis. Tool layers appear in Tools for Label-free Peptide Quantification.

Parameters That Must Be Locked Across Unlabeled Quant Work

Layer

Parameter that must be declared

Failure mode if ignored

Contrast

Groups and claim unit before tuning

Post hoc relabeling

Prep

Matched extraction and digest

Peptide pool shifts

Enrichment

Co-IP, pull-down, or fractionation parity

Bait arm-only artifacts

Injection

Separate unlabeled runs

Multiplex assumptions

Acquisition

DDA or DIA template fixed

Mixed modes in one matrix

Quant metric

MS1 LFQ versus spectral counting

Incomparable fold changes

Search

FDR, database, modifications

Inflated ID-driven counts

Normalization

Method and scope

Global drift as biology

Missing values

Filter and imputation policy

Hidden model bias

Processing

One pipeline version per block

Mid-cohort drift

Limits follow the same table. Unlabeled quantitative work on enriched baits or subcellular fractions still needs control arms and realistic expectations for quantifiable depth (How Many Proteins Can Label-Free Detect?). Low-complexity pulls simplify interpretation but do not remove nonspecific binding or run-order confounding (Lazar et al. 2016).

Quality integration appears in How to Improve Data Quality and Reproducibility in Label-Free Proteomics?. Tradeoffs appear in Advantages of Label-Free Proteomics Analysis.

How to Choose Unlabeled Versus Other Quantitative Proteomics Routes

Use enrollment, matrix complexity, metric need, and follow-up unit together.

Quantitative proteomics need

Route that often fits

Recheck before committing

Large open cohort, staggered samples

Unlabeled LFQ separate injections

Spectral counting as sole metric

Closed arms, one labeling day

TMT or iTRAQ multiplex

Forced unlabeled when tags required

Cultivable SILAC system

Metabolic labeled quant

Label-free when media routing fails

High DDA missingness

Unlabeled DIA quantitative pilot

DDA when DIA adds little

Co-IP or pull-down contrast

Matched controls; MS1 LFQ

ID counts alone in complex binders

Amount on named peptides

SIS or PRM targeted quant

Discovery LFQ as concentration

Cross-study absolute scale

Not from open unlabeled LFQ

iBAQ or targeted calibration scope

Choosing unlabeled quantitative proteomics versus labeled multiplex or targeted quantitative routes by enrollment, metric, and follow-up claim

Figure 2. Unlabeled quantitative proteomics fits open relative discovery; labeled multiplex or targeted quant fit other enrollment and claim patterns.

Decode context appears in Decoding Proteomics: A Dive into Label-Free Technology. iBAQ contrast appears in What Is the Difference between LFQ and iBAQ?.

Teams with matrix documentation, contrast map, and metric choice can review the MtoZ Biolabs Label-Free Quantitative Proteomics Service for unlabeled quantitative proteomics alignment when declared in the project record.

Frequently Asked Questions

1. Is unlabeled quantitative proteomics the same as label-free quantification?

Unlabeled quantitative proteomics is the project theme. LFQ is the common intensity-based relative readout on unlabeled injections. Spectral counting is another unlabeled readout with narrower fit.

2. When is spectral counting acceptable?

In low-complexity mixtures or rough ranking when MS1 LFQ is not configured, spectral counting may suffice. Complex lysates and group statistics usually need MS1 or DIA intensity LFQ on the same design.

3. Does unlabeled quant avoid all labeling steps?

Discovery injections are unlabeled. Some projects add parallel SIS or PRM assays on the same study questions, which is a separate quantitative block.

4. Can unlabeled quantitative proteomics replace targeted assays?

Open unlabeled discovery prioritizes breadth on a contrast. Targeted quantitative proteomics on named peptides supports follow-up amount or specification-style reporting.

5. What should clients document before service scoping?

Matrix, contrast arms, replicates, pretreatment parity, pilot availability, preferred acquisition mode, and whether the claim is relative discovery or targeted follow-up. Cell culture or labeling scope, when needed, must match the chemistry declared in the brief, not assumed from an unlabeled discovery page.

MtoZ Biolabs can discuss unlabeled quantitative proteomics when contrast design, locked methods, and follow-up intent are documented.

If further evaluation of DDA versus unlabeled DIA pilots, metric choice, or discovery-to-targeted staging is needed, project details can be submitted for a feasibility review.

Reference

  1. M. Bantscheff, S. Lemeer, H.U. Haab, B. Kuster (2012). Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem., 404, 939-965. https://doi.org/10.1007/s00216-012-5892-4
  2. J. Cox, M.Y. Hein, C.A. Luber, I. Paron, M. Mann (2014). Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics, 13, 2513-2526. https://doi.org/10.1074/mcp.M113.031031
  3. L.C. Gillet, P. Navarro, S. Tate, H. Rost, N. Selevsek, L. Reiter, R. Bonner, R. Aebersold (2012). Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics, 11, O111.016717. https://doi.org/10.1074/mcp.O111.016717
  4. C. Lazar, L. Gatto, M. Ferro, C. Bruley, T. Burger (2016). Accounting for the multiple natures of missing values in label-free quantitative proteomics data sets to compare imputation strategies. J. Proteome Res., 15, 1116-1125. https://doi.org/10.1021/acs.jproteome.5b00981
  5. S.A. Gerber, J. Rush, O. Stemman, M.W. Kirschner, S.P. Gygi (2003). Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A., 100, 6940-6945. https://doi.org/10.1073/pnas.0832254100

Support Documents

Protein Quantification for Deeper Discovery

Gain a clearer understanding of protein quantification approaches and their applications in studying protein abundance changes by downloading our detailed brochure.

Submit the form below to download the
This checkbox is required
* I agree to receive other communications from MtoZ Biolabs, which may contain technical or marketing information. You can unsubscribe from thlese communications at any time.
SUBMIT
 

How to Order

How to Order
Request a Quote

Request a Project Quote

Please complete the required fields below. We will review your information and respond with a tailored recommendation.

Project inquiry

Fields marked with * are required for quote review.

Secure inquiry · No obligation
Required Information

Your information will be used only to respond to your inquiry.

Submit Inquiry